KNSA vs MDT: fair value comparison
Kiniksa Pharmaceuticals International, plc and Medtronic plc · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, KNSA currently sits closer to the top of our discount ranking. MDT carries the stronger quality grade.
| KNSA | MDT | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $73.41 | $91.23 |
| 12-month range | $34.28–$73.41 | $73.98–$103.34 |
| Sector rank | #58 of 113 Healthcare | #59 of 113 Healthcare |
| Quality grade | D | C |
| Momentum grade | — | D |
| Leverage | Low | Moderate |
| Margin trend | — | Contracting |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: KNSA fair value analysis · MDT fair value analysis